Medicines Classification




NEW ZEALAND GAZETTE

No. 106

Isoetharine; and its salts; except when contained in medicines for inhalation or for parenteral use

Ketoprofen; and its salts; in tablets or capsules containing 25 mg or less of ketoprofen and in pack sizes of not more than 30 tablets or capsules

Levocabastine

Mercury oxides

Mercury, ammoniated

Mercury; and its salts; and its compounds

Metoclopramide; when compounded with paracetamol and in a pack size of not more than ten tablets or capsules

Miconazole; in medicines for buccal use; and for vaginal use when in pack sizes equivalent to one course of treatment

Minoxidil; in medicines for external use

Mupirocin; and its salts

Naproxen; and its salts; in tablets or capsules containing 250 mg or less of naproxen and in pack sizes of not more than 30 tablets or capsules

Nicotinamide; in medicines containing more than 100 mg per dose form

Nicotinic acid; in medicines containing more than 100 mg per dose form

Nicotinyl alcohol; in medicines containing more than 100 mg per dose form

Nitrite, butyl

Nitrite, isobutyl

Nitrite, octyl

Nystatin; in medicines for buccal use; and for vaginal use when in pack sizes equivalent to one course of treatment

Orciprenaline; and its salts; in medicines for oral use

Papaverine; and its salts

Podophyllum extracts; tinctures of podophyllum; podophyllum; in medicines containing 20% or less of podophyllum

Pralidoxime; and its salts

*Prochlorperazine; for buccal use in medicines which are sold in the manufacturer’s original pack containing not more than 10 tablets for the treatment of nausea associated with migraine

Quinine; and its salts; in medicines containing 200 mg or less per dose form and in packs containing not more than 5 days’ supply for the treatment of cramp

Reproterol; and its salts; except in medicines for inhalation or for parenteral use

Rimiterol hydrobromide; except in medicines for inhalation or for parenteral use

Salbutamol; and its salts; except in medicines for inhalation or for parenteral use

Solanaceous alkaloids; and their salts; in medicines not specified elsewhere in this notice; and in medicines containing 0.15% and less of solanaceous alkaloids calculated as hyoscyamine; except in forms for parenteral use

Sulphacetamide; and its salts; in ophthalmological medicines

Terbutaline; and its salts; except in medicines for inhalation, or for parenteral use

Terfenadine

Tioconazole; and its salts; in medicines for vaginal use when in pack sizes equivalent to one course of treatment

Triamcinolone acetonide; in medicines for buccal use and when in a pack containing 5 mg or less of triamcinolone acetonide

Tolubuterol; and its salts; except in medicines for inhalation or for parenteral use

Regulation 20 of the Medicines Regulations 1984 requires that all medicines sold without a practitioner’s prescription must include a consumer information panel on the label. Further, all material changes to a medicine (including changes to labelling), must be notified to the Director-General of Health in accordance with section 24 of the Medicines Act 1981.

Schedule 3

Pharmacy-Only Medicines

Aciclovir; for the treatment of herpes labialis

Acrivastine

Amethocaine; and its salts; in medicines for external use except in medicines for ophthalmological use

Aminophylline; in liquid form for oral use

Amyl nitrite; except when sold from outlets licensed under the Toxic Substances Regulations 1983 to sell sodium cyanide paste for the purpose of vertebrate pest control

Azelaic acid

Benzocaine; for external use in medicines containing more than 2%

Benzoyl peroxide; in medicines for external use containing more than 5% of benzoyl peroxide

Benzydamine; and its salts

Benzyl benzoate; in medicines containing more than 2.5% of benzyl benzoate

Biphenylacetic acid

Bisacodyl

Bithionol

Bufexamac

Calcium glucono-galacto-gluconate; for parenteral use

Camphorated oil

Carbetapentane; in medicines containing more than 0.5%

Carboxymethylcysteine

Cetirizine; and its salts

Chlophedianol hydrochloride

Ciclopirox; for dermatological use in medicines containing 1% or less of ciclopirox

Cinchocaine; for external use in medicines containing more than 2%

Clidinium; and its salts

Desoxyribonuclease; for external use

Dextranomer

Dextromethorphan; and its salts; in medicines containing more than 0.25% of dextromethorphan

Diclofenac; and its salts; in medicines for external use but not ophthalmological use

Dicyclomine; and its salts

Dimenhydrinate; and its salts; except in a sealed container of not more than 12 tablets or capsules, labelled for the prevention of travel sickness and sold at a transport terminal or aboard a ship or plane

Emetine; and its salts; in medicines containing more than 0.05%

Ether; when used as a vehicle for a topical dose form

Fluorescein

Fluorides; in medicines for internal use containing 2.2 milligrams or less of fluoride per dosage unit; in medicines



Next Page →

PDF embedding disabled (Crown copyright)

View this page online at:


VUW Te Waharoa PDF NZ Gazette 1996, No 106


NZLII PDF NZ Gazette 1996, No 106





✨ LLM interpretation of page content

🏥 Classification of Medicines (continued from previous page)

🏥 Health & Social Welfare
Classification, Medicines, Prescription Medicines, Restricted Medicines, Pharmacy-only Medicines